The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11150 malaria professionals are enjoying the free benefits of MalariaWorld today

Afghanistan

Open Access | Field trial of three different Plasmodium vivax-detecting rapid diagnostic tests with and without evaporative cool box storage in Afghanistan

June 23, 2011 - 14:08 -- Kabogo Ndegwa
Author(s): 
Mikhail AF, Leslie TJ, Mayan MI, Zekria R, Mohammad N, Hasanzai MA, Safi N, Whitty CJ, Rowland M
Reference: 
Malaria Journal 2011, 10:169 (22 June 2011)

Of the three RDTs, the CSPfPan test was the most consistent and reliable, rendering it appropriate for this P. vivax predominant region.

Country: 
Medical Condition: 
Medical Treatment: 

Amodiaquine Resistance in Plasmodium falciparum Malaria in Afghanistan Is Associated with the pfcrt SVMNT Allele at Codons 72 to 76

August 18, 2010 - 12:48 -- Kabogo Ndegwa
Author(s): 
Khalid Beshir, Colin J. Sutherland, Ioannis Merinopoulos, Naeem Durrani, Toby Leslie, Mark Rowland, and Rachel L. Hallett
Reference: 
Antimicrobial Agents and Chemotherapy, September 2010, p. 3714-3716, Vol. 54, No. 9

Mutations in the Plasmodium falciparum genes pfcrt and pfmdr1 are selected by amodiaquine treatment in Africa.

Country: 

Open Access | Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial

April 22, 2010 - 13:34 -- Kabogo Ndegwa
Author(s): 
Awab G, Pukrittayakamee S, Imwong M, Dondorp AM, Woodrow CJ, Lee S, Day NP, Singhasivanon P, White NJ, Kaker F
Reference: 
Malaria Journal 2010, 9:105 (21 April 2010)

Chloroquine remains an efficacious treatment for the treatment of vivax malaria in Afghanistan. In a setting where radical therapy cannot be administered, dihydroartemisinin-piperaquine provides additional benefit in terms of post-treatment prophylaxis, reducing the incidence of recurrence from 4-8 weeks after treatment. Trial Registration The trial was registered at ClinicalTrials.gov under identifier NCT00682578.

Country: 
Medical Condition: 

Open Access | Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan

March 14, 2010 - 10:35 -- Ingeborg van Schayk
Author(s): 
Sedigheh Zakeri, Mandana Afsharpad, Faezeh Ghasemi, Ahmad Raeisi, Najibullah Safi, Waqar Butt, Hoda Atta, Navid D Djadid
Reference: 
Malaria Journal 2010, 9:75 (14 March 2010)

The present study shows a limited polymorphism in pvdhfr from Afghan isolates and provides important basic information to establish an epidemiological map of drug-resistant vivax malaria, and updating guidelines for anti-malarial policy in Afghanistan.

Country: 
Medical Condition: 

Open Access | Malaria control under the Taliban regime: insecticide-treated net purchasing, coverage, and usage among men and women in eastern Afghanistan

January 13, 2010 - 11:27 -- Ingeborg van Schayk
Author(s): 
Natasha Howard, Ahmad Shafi, Caroline Jones, Mark Rowland
Reference: 
Malaria Journal 2010, 9:7 (6 January 2010)

The paper provides an important contribution to information about malaria control in complex humanitarian settings, which is lacking in the current literature, as well as demonstrates the ability to conduct operational research in very restrained circumstances.

Person: 
Country: 
Medical Condition: 

Pages

Subscribe to RSS - Afghanistan